Skip to main content

Daiichi Sankyo Ltd(DSKYF)
OTC US

Today's Change
Delayed Last Update
Day Low27.6000
Day High30.3500
Open:27.7600
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news

Profile

Daiichi Sankyo Co Ltd was founded on September 28, 2005. The Company is engaged in the research, development, manufacture, sale and marketing of pharmaceutical products. Its principal products include Olmesartan, an anti-hypertensive agent; Prasugrel, an antiplatelet agent; Memary and Donepezil for the treatment of alzheimer's disease; Nexium for treating reflux esophagitis; Inavir, an anti-influenza treatment product; ActHIB, a haemophilus b conjugate vaccine; and Loxonin S, an analgesic and anti-inflammatory drug; Denosumab, an antibody for the treatment and prevention of various bone disorders; and Edoxaban, an oral anticoagulant product. The Company also markets therapies in hypertension, dyslipidemia, diabetes, acute coronary syndrome, and metastatic melanoma.